ClinicalTrials.Veeva

Menu

Single-cycle Remote Ischemic Preconditioning and Postconditioning for Prevention of Contrast-Induced Nephropathy

P

Phramongkutklao College of Medicine and Hospital

Status

Unknown

Conditions

Ischemic Reperfusion Injury

Treatments

Procedure: RIPost
Procedure: Sham-Post
Procedure: RIPre
Procedure: Sham-Pre

Study type

Interventional

Funder types

Other

Identifiers

NCT02729155
PMK-SCRIP-CIN

Details and patient eligibility

About

This trial is a 2 x 2 factorial design, double-blinded, randomized controlled trial to evaluate efficacy and safety of remote ischemic preconditioning and postconditioning for prevention of contrast-induced acute kidney injury in patient undergoing coronary angiography and angioplasty

Full description

randomized controlled trial

Enrollment

596 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient have indication for coronary angiography or angioplasty.
  • Impaired renal function with reduced eGFR < 60 ml/min/1.73 m2 by CKD-EPI equation.
  • Written informed consent.

Exclusion criteria

  • History of contrast allergy.
  • The patient had end-stage renal failure with the need for hemodialysis.
  • The patient take medications that affect the kidneys function within 48 hours before study.
  • The patient had acute kidney injury from any cause.
  • The patient was received contrast media within 2 weeks before study.
  • The patient had cardiac arrest or shock.
  • The patient had peripheral arterial disease (PAD)
  • Pregnancy
  • Refused to study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

596 participants in 4 patient groups

RIPre + RIPost
Experimental group
Description:
Intervention: RIPre 200 mmHg + RIPost 200 mmHg
Treatment:
Procedure: RIPost
Procedure: RIPre
RIPre + Sham
Experimental group
Description:
Intervention: RIPre 200 mmHg + Sham 10 mmHg
Treatment:
Procedure: RIPre
Procedure: Sham-Post
Sham + RIPost
Experimental group
Description:
Intervention: Sham 10 mmHg + RIPost 200 mmHg
Treatment:
Procedure: Sham-Pre
Procedure: RIPost
Sham + Sham
Sham Comparator group
Description:
Intervention: Sham 10 mmHg + Sham 10 mmHg
Treatment:
Procedure: Sham-Pre
Procedure: Sham-Post

Trial contacts and locations

1

Loading...

Central trial contact

Pawit Pipatwattanakul, MD; Nakarin Sansanayudh, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems